Hao-Yuan Chuang sold $13M of BLTE
Chief Financial Officer at BELITE BIO, INC. 67,395 shares at an average of $189.98, traded Sep 4, 2026, filed Sep 9, 2026.
Score components
- +22RoleCFO
- +25Trade size$12.8M at market
- +20Share of holdings soldSold 72% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-386790, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -1,633 | $180.16 | $294k | 91,800 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -2,000 | $181.05 | $362k | 89,800 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -2,000 | $182.49 | $365k | 87,800 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -3,759 | $183.27 | $689k | 84,041 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -3,569 | $184.57 | $659k | 80,472 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -3,872 | $185.28 | $717k | 76,600 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -4,600 | $186.35 | $857k | 72,000 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -3,900 | $187.16 | $730k | 68,100 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -1,900 | $188.59 | $358k | 66,200 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -6,200 | $189.22 | $1.2M | 60,000 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -1,800 | $190.63 | $343k | 58,200 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -6,200 | $191.09 | $1.2M | 52,000 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -3,398 | $192.40 | $654k | 48,602 | 35 d ago |
| Sep 4, 2026 | SOpen-market sale American depositary share10b5-1 | -4,602 | $193.12 | $889k | 44,000 | 35 d ago |
| Sep 8, 2026 | SOpen-market sale American depositary share10b5-1 | -2,200 | $194.28 | $427k | 41,800 | 35 d ago |
| Sep 8, 2026 | SOpen-market sale American depositary share10b5-1 | -4,120 | $195.60 | $806k | 37,680 | 35 d ago |
| Sep 8, 2026 | SOpen-market sale American depositary share10b5-1 | -4,475 | $196.47 | $879k | 33,205 | 35 d ago |
| Sep 8, 2026 | SOpen-market sale American depositary share10b5-1 | -4,605 | $197.23 | $908k | 28,600 | 35 d ago |
| Sep 8, 2026 | SOpen-market sale American depositary share10b5-1 | -2,562 | $198.05 | $507k | 26,038 | 35 d ago |
Related signals
Other insiders at BELITE BIO, INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 4Weak | BELITE BIO, INC | Hendrik Peter Scholl Chief Medical Officer | $83k 500 shares | -3% | |
| 58Moderate | BELITE BIO, INC | Yu-Hsin Lin Chief Executive Officer | $19M 100,435 shares | -59% | |
| 21Weak | BELITE BIO, INC | Yu-Hsin Lin Chief Executive Officer | $66k 365 shares | -0% | |
| 18Weak | BELITE BIO, INC | Hao-Yuan Chuang Chief Financial Officer | $66k 367 shares | -0% | |
| 50Moderate | BLTEsell BELITE BIO, INC | Hendrik Peter Scholl Chief Medical Officer | $1.5M 10,000 shares | -40% | |
| 50Moderate | BLTEsell BELITE BIO, INC | Hendrik Peter Scholl Chief Medical Officer | $1.4M 10,000 shares | -29% | |
| 25Weak | BELITE BIO, INC | Nathan L. Mata Chief Scientific Officer | $102k 666 shares | -100% | |
| 26Weak | BELITE BIO, INC | Nathan L. Mata Chief Scientific Officer | $154k 1,000 shares | -60% | |
| 16Weak | BELITE BIO, INC | Nathan L. Mata Chief Scientific Officer | $156k 1,000 shares | -38% | |
| 16Weak | BELITE BIO, INC | Nathan L. Mata Chief Scientific Officer | $156k 1,000 shares | -27% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.